| 0 (0%) | 11-30 07:30 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 3.24 |
1-year : | 4.97 |
| Resists | First : | 2.77 |
Second : | 4.26 |
| Pivot price | 2.64 |
|||
| Supports | First : | 0.37 |
Second : | 0.3 |
| MAs | MA(5) : | 1.03 |
MA(20) : | 2.97 |
| MA(100) : | 5.09 |
MA(250) : | 10.16 |
|
| MACD | MACD : | -0.9 |
Signal : | -0.6 |
| %K %D | K(14,3) : | 0.5 |
D(3) : | 2 |
| RSI | RSI(14): 16 |
|||
| 52-week | High : | 17.1 | Low : | 0.37 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ CLSD ] has closed above bottom band by 6.6%. Bollinger Bands are 82.8% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 2 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 0.65 - 0.66 | 0.66 - 0.66 |
| Low: | 0.54 - 0.55 | 0.55 - 0.55 |
| Close: | 0.55 - 0.56 | 0.56 - 0.57 |
Thu, 27 Nov 2025
Clearside Biomedical, Inc.(NasdaqGM: CLSD) dropped from S&P TMI Index - MarketScreener
Mon, 24 Nov 2025
CLSD Stock Plummets After Company Files For Bankruptcy Protection - MSN
Mon, 24 Nov 2025
Clearside Biomedical (CLSD) Files for Chapter 11 Bankruptcy - GuruFocus
Mon, 24 Nov 2025
Why Is Clearside Biomedical Stock (CLSD) Down Today? - TipRanks
Mon, 24 Nov 2025
Clearside Biomedical files for Chapter 11 (CLSD:NASDAQ) - Seeking Alpha
Mon, 24 Nov 2025
Clearside Biomedical (Nasdaq: CLSD) Starts Chapter 11, Plans Section 363 Asset Sale - Stock Titan
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 5 (M) |
| Shares Float | 5 (M) |
| Held by Insiders | 12.8 (%) |
| Held by Institutions | 13.7 (%) |
| Shares Short | 85 (K) |
| Shares Short P.Month | 143 (K) |
| EPS | -5.41 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | -9.32 |
| Profit Margin | 0 % |
| Operating Margin | -725.3 % |
| Return on Assets (ttm) | -55.5 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 446.7 % |
| Gross Profit (p.s.) | 0.72 |
| Sales Per Share | 0.79 |
| EBITDA (p.s.) | -4.12 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -22 (M) |
| Levered Free Cash Flow | -21 (M) |
| PE Ratio | -0.08 |
| PEG Ratio | 0 |
| Price to Book value | -0.05 |
| Price to Sales | 0.51 |
| Price to Cash Flow | -0.1 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|